These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17531556)

  • 41. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical utility of serological markers in inflammatory bowel disease.
    Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
    Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].
    Papp M
    Orv Hetil; 2008 Nov; 149(48):2269-76. PubMed ID: 19028649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.
    Sendid B; Dotan N; Nseir S; Savaux C; Vandewalle P; Standaert A; Zerimech F; Guery BP; Dukler A; Colombel JF; Poulain D
    Clin Vaccine Immunol; 2008 Dec; 15(12):1868-77. PubMed ID: 18971303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
    Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
    Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Candida albicans colonization and ASCA in familial Crohn's disease.
    Standaert-Vitse A; Sendid B; Joossens M; François N; Vandewalle-El Khoury P; Branche J; Van Kruiningen H; Jouault T; Rutgeerts P; Gower-Rousseau C; Libersa C; Neut C; Broly F; Chamaillard M; Vermeire S; Poulain D; Colombel JF
    Am J Gastroenterol; 2009 Jul; 104(7):1745-53. PubMed ID: 19471251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn's disease.
    Eser A; Papay P; Primas C; Pernicka E; Harrer M; Dejaco C; Novacek G; Lichtenberger C; Angelberger S; Kazemi L; Mikulits A; Vogelsang H; Reinisch W
    Aliment Pharmacol Ther; 2012 Jan; 35(2):292-9. PubMed ID: 22146122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.
    Montanelli A; Mainardi E; Vagni A; Villanacci V; Zambelli C; Cestari R; Cengia P; Minelli L; Missale G
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):201-7. PubMed ID: 15990710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease.
    El-Matary W; Dupuis K; Sokoro A
    Acta Paediatr; 2015 Aug; 104(8):827-30. PubMed ID: 25877674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TNFalpha genotype influences development of IgA-ASCA antibodies in Crohn's disease patients with CARD15 wild type.
    Castro-Santos P; Mozo L; Gutiérrez C; Suárez A
    Clin Immunol; 2006 Dec; 121(3):305-13. PubMed ID: 16952484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-reactivity of yeast antigens in human colon and peripheral leukocytes.
    Oshitani N; Hato F; Suzuki K; Sawa Y; Matsumoto T; Maeda K; Higuchi K; Kitagawa S; Arakawa T
    J Pathol; 2003 Mar; 199(3):361-7. PubMed ID: 12579538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequency and clinical correlations of granulomas in children with Crohn disease.
    De Matos V; Russo PA; Cohen AB; Mamula P; Baldassano RN; Piccoli DA
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):392-8. PubMed ID: 18367950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease.
    Smith BR; Arnott ID; Drummond HE; Nimmo ER; Satsangi J
    Inflamm Bowel Dis; 2004 Sep; 10(5):521-8. PubMed ID: 15472511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Significance of serum antibodies ANCA, ASCA, ABBA in diagnostics of idiopathic intestinal inflammations].
    Pintér M; Pintérová KM; Drahosová M; Rejchrt S; Douda T; Tachecí I; Kopácová M; Bures J
    Cas Lek Cesk; 2007; 146(11):863-7. PubMed ID: 18069213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mortality and cause of death in Japanese patients with Crohn's disease.
    Uno H; Yao T; Matsui T; Sakurai T; Iida M; Matsumoto T; Aoyagi K; Fuchigami T
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S15-21. PubMed ID: 14530654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease.
    Klebl FH; Bataille F; Bertea CR; Herfarth H; Hofstädter F; Schölmerich J; Rogler G
    Inflamm Bowel Dis; 2003 Sep; 9(5):302-7. PubMed ID: 14555913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polypharmacy and Crohn's disease.
    Cross RK; Wilson KT; Binion DG
    Aliment Pharmacol Ther; 2005 May; 21(10):1211-6. PubMed ID: 15882241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Crohn's disease: influence of age at diagnosis on clinical type of disease].
    Elloumi H; Sfar S; Ben Abdelaziz A; Arfaoui D; Mouna G; Ajmi S
    Tunis Med; 2007 Oct; 85(10):862-5. PubMed ID: 18236809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.